Zhurnal «Patologicheskaia fiziologiia i eksperimental`naia terapiia»,
Journal Year:
2023,
Volume and Issue:
67(2), P. 33 - 41
Published: June 27, 2023
Цель
работы
–
исследовать
ассоциацию
между
показателями
гемостаза
и
полиморфизмом
генов,
обеспечивающих
его
реализацию
у
пациентов
с
COVID-19-ассоциированным
повреждением
легких
в
зависимости
от
тяжести
клинического
течения.
Методика.
В
исследовании
принимали
участие
46
больных
COVID-19,
которые
поражения
разделены
на
2
группы:
поражением
до
50%
паренхимы
(n
=
22)
более
24).
Контрольная
группа
практически
здоровые
люди
15),
сопоставимые
по
полу
возрасту.
У
всех
лиц
начала
терапии
исследовали
протромбиновое
время,
активированное
частичное
тромбопластиновое
тромбиновое
уровень
фибриногена
Д-димера
крови,
XII-зависимый
фибринолиз
активность
антитромбина;
методом
полимеразной
цепной
реакции
определяли
полиморфизмы
rs1799963
гена
F2,
rs6025
F5,
rs1800790
FGB
rs1799889
PAI-1.
Анализ
полученных
данных
проводили
помощью
пакета
прикладных
программ
IBM
SPSS
Statistics
v.
23.
Результаты.
COVID-19-ассоциированном
поражении
при
средней
тяжелой
степени
заболевания
происходит
активация
коагуляционного
за
счет
внешнего
общего
пути,
замедляется
снижается
антитромбина
сравнению
со
здоровыми
лицами,
этом
выраженность
прокоагулянтных
изменений
увеличивается
группе
тяжелым
течением
болезни;
характерно
увеличение
частоты
встречаемости
мутантных
аллелей
полиморфизма
rs179996
F2
контролем;
наблюдается
снижение
немутантых
гомозигот
повышение
гетерозигот;
частота
патологических
мутаций
FGB,
PAI-1
значимо
не
меняется;
выявлена
обратная
связь
слабой
силы
гетерозиготным
вариантом
GA
протромбиновым
временем
заболевании
тяжести,
выявлено
значимой
связи
полиморфизмами
The
aim
of
this
work
was
to
study
the
association
between
hemostasis
and
related
genetic
polymorphisms
in
patients
with
COVID-19-associated
lung
injury
depending
on
its
severity.
Methods.
included
COVID-19
divided
into
two
groups
based
severity
injury:
up
parenchyma
more
than
control
group
consisted
sex-
age-matched
practically
healthy
individuals
15).
Before
start
therapy,
all
subjects
were
assessed
for
prothrombin
time,
activated
partial
thromboplastin
thrombin
blood
concentrations
fibrinogen
D-dimer,
XII-dependent
fibrinolysis,
antithrombin
activity.
Polymorphisms
gene,
F5
gene
determined
by
polymerase
chain
reaction.
Data
analyzed
23
application
software
package.
Results.
In
moderate
severe
injury,
activation
coagulation
observed,
which
due
external
common
pathways,
slower
reduced
activity
compared
individuals.
Procoagulant
changes
significantly
pronounced.
disease,
who
had
a
characteristic
increase
frequency
mutant
alleles
polymorphism
control,
decreased
non-mutant
homozygotes,
increased
heterozygotes.
occurrence
pathological
mutations
did
not
change.
A
weak
inverse
correlation
found
heterozygous
variant
time
moderately
strong
disease
injury.
There
no
significant
parameters
gene.
Biomedicines,
Journal Year:
2024,
Volume and Issue:
12(3), P. 639 - 639
Published: March 13, 2024
SARS-CoV-2
infection
is
a
significant
health
concern
that
needs
to
be
addressed
not
only
during
the
initial
phase
of
but
also
after
hospitalization.
This
consequence
various
pathologies
associated
with
long
COVID-19,
which
are
still
being
studied
and
researched.
Lung
fibrosis
an
important
complication
found
in
up
71%
patients
discharge.
Our
research
based
on
scientific
articles
indexed
PubMed;
selection
process,
we
used
following
keywords:
“lung
fibrosis”,
“fibrosis
mediators”,
predictors”,
“COVID-19”,
“SARS-CoV-2
infection”,
“long
COVID-19”.
In
this
narrative
review,
aimed
discuss
current
understanding
mechanisms
initiation
progression
post-COVID-19
lung
(PC-19-LF)
risk
factors
for
its
occurrence.
The
pathogenesis
pulmonary
involves
mediators
such
as
TGF-β,
legumain,
osteopontin,
IL-4,
IL-6,
IL-13,
IL-17,
TNF-α,
Gal-1,
Gal-3,
PDGF,
FGFR-1.
key
cellular
effectors
involved
COVID-19
macrophages,
epithelial
alveolar
cells,
neutrophils,
fibroblasts.
main
pathways
include
hypoxemia-induced
fibrosis,
macrophage-induced
viral-fibroblast
interaction-induced
fibrosis.
Biomedicines,
Journal Year:
2023,
Volume and Issue:
11(3), P. 929 - 929
Published: March 16, 2023
COVID-19,
the
infectious
disease
caused
by
severe
acute
respiratory
syndrome
coronavirus-2
(SARS-CoV-2),
is
frequently
associated
with
pulmonary
thrombotic
events,
especially
in
hospitalized
patients.
Severe
SARS-CoV-2
infection
characterized
a
proinflammatory
state
and
an
disbalance
hemostasis.
Immune
pathology
analysis
supports
inflammatory
nature
of
arterial
thrombi
composed
white
blood
cells,
neutrophils,
CD3+
CD20+
lymphocytes,
fibrin,
red
platelets.
cytokines,
chemokines,
complement
system
are
key
drivers
immunothrombosis,
as
they
induce
damage
endothelial
cells
initiate
procoagulant
positive
feedback
loops.
Neutrophil
extracellular
traps
induced
COVID-19-associated
“cytokine
storm”,
platelets,
coagulation
pathways
close
inflammation–endotheliopathy–thrombosis
axis,
contributing
to
SARS-CoV-2-associated
events.
The
hypothesis
immunothrombosis
also
supported
minor
role
venous
thromboembolism
chest
CT
imaging
data
showing
peripheral
clots
lesions
high
incidence
events
despite
routine
thromboprophylaxis.
Understanding
complex
mechanisms
behind
COVID-19-induced
thrombosis
will
lead
future
combination
therapies
for
patients
that
would
target
crossroads
pathways.
European Journal of Medicinal Chemistry Reports,
Journal Year:
2023,
Volume and Issue:
10, P. 100125 - 100125
Published: Dec. 12, 2023
The
current
coronavirus
disease
2019
(COVID-19)
outbreak,
caused
by
the
infection
of
SARS-CoV-2,
seems
to
be
a
tough
global
challenge
because
its
highly
contagious
nature
and
rapid
evolution
virus
strain.
As
no
effective
clinical
drugs
are
available
for
treatment
this
in
early
phase
till
date,
scientists
hunting
from
natural
sources
treatment.
Quercetin,
dietary
polyphenolic
flavonoid
found
fruits
vegetables,
has
been
reported
exhibit
various
health-benefit
pharmacological
properties
including
antioxidant,
anti-inflammatory,
antimicrobial,
antiviral
anticancer
properties.
In
silico
vitro
studies
demonstrated
that
quercetin
potently
inhibits
infections
SARS-CoV-2
other
coronaviruses
interfering
with
viral
entry
replication
via
inhibiting
activity
host
ACE2
receptor,
S-,
3CL-,
PL-,
RdRp-
Nsp13
-
proteases.
Moreover,
is
able
suppress
oxidative
stress,
cytokine
storm,
thrombosis,
sepsis
lung
fibrosis,
thereby
very
likely
mitigate
COVID-19
infection.
review
article,
we
elaborately
discussed
antiviral,
immunomodulatory,
antioxidant
against
diseases,
as
well
on
nanoformulations
enhancement
oral
bioavailability
efficacy
development
drug
COVID-19.
Scientific Reports,
Journal Year:
2024,
Volume and Issue:
14(1)
Published: July 2, 2024
Abstract
Sepsis
is
a
severe
disease
characterized
by
high
mortality
rates.
Our
aim
was
to
develop
an
early
prognostic
indicator
of
adverse
outcomes
in
sepsis,
utilizing
easily
accessible
routine
blood
tests.
A
retrospective
analysis
sepsis
patients
from
the
MIMIC-IV
database
conducted.
We
performed
univariate
and
multivariate
regression
analyses
identify
independent
risk
factors
associated
with
in-hospital
within
28
days.
Logistic
utilized
combine
neutrophil-to-lymphocyte
ratio
(NLR)
neutrophil-to-platelet
(NPR)
into
composite
score,
denoted
as
NLR_NPR.
used
ROC
curves
compare
performance
models
Kaplan–Meier
survival
assess
day
rate.
Subgroup
evaluate
applicability
NLR_NPR
different
subpopulations
based
on
specific
characteristics.
This
study
included
total
1263
patients,
whom
179
died
days
hospitalization,
while
1084
survived
beyond
Multivariate
identified
age,
respiratory
rate,
(NLR),
(NPR),
hypertension,
sequential
organ
failure
assessment
(SOFA)
score
for
septic
(P
<
0.05).
Additionally,
prediction
model
cell-related
parameters,
combined
exhibited
highest
predictive
value
(AUC
=
0.6666),
followed
NLR
0.6456)
NPR
0.6284).
Importantly,
superior
that
commonly
SOFA
0.5613).
showed
remained
factor
subgroups
SOFA,
although
not
hypertension
subgroup.
The
use
tests
represents
readily
available
reliable
marker
patients.
These
results
imply
clinicians
should
prioritize
higher
scores
closer
monitoring
reduce
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(5), P. 1965 - 1965
Published: Feb. 25, 2025
Neutrophils
play
a
key
role
in
inflammatory
responses
and
thrombosis,
but
their
complex
interactions
disease
pathogenesis
are
not
fully
understood.
This
review
examines
the
multifaceted
roles
of
neutrophils,
focusing
on
activation,
cytokine
release,
formation
neutrophil
extracellular
traps
(NETs),
which
contribute
to
host
defense
thrombosis.
We
discuss
interaction
between
inflammation
coagulation,
direct
effect
neutrophils
thrombus
stability,
involvement
pathological
thrombotic
diseases.
The
therapeutic
potential
drug
loading
treatment
as
well
clinical
implications
future
research
directions,
highlighted.
aim
this
is
gain
insight
into
critical
neutrophil-inflammation-thrombus
axis
its
target
for
diseases
suggest
possible
directions
neutrophil-loaded
therapy
BMC Infectious Diseases,
Journal Year:
2024,
Volume and Issue:
24(1)
Published: Dec. 2, 2024
This
systematic
review
and
meta-analysis
study
evaluated
the
association
between
mortality
due
to
COVID-19
coagulative
factors.
A
search
was
conducted
on
electronic
databases
including
PubMed,
Scopus,
Web
of
Science
from
beginning
pandemic
until
October
2024
identify
relevant
studies
patients
their
laboratory
findings
related
coagulation
markers
outcome.
Eligibility
criteria
were
defined
based
PICO
framework,
data
extraction
performed
by
two
authors
independently
using
a
standardized
sheet.
Statistical
analysis
accomplished
random
effects
model,
heterogeneity
among
assessed
I2
test.
R
RStudio
used
for
statistical
visualization.
Our
literature
yielded
6969
studies,
with
48
meeting
inclusion
our
meta-analysis.
The
mean
platelet
count
significantly
lower
in
deceased
compared
survivors
(20.58),
while
activated
partial
thromboplastin
time
(aPTT)
fibrinogen
levels
did
not
show
significant
differences.
pooled
difference
D-Dimer,
International
Normalized
Ratio
(INR),
prothrombin
(PT)
survived
(-2.45,
-0.10,
-0.84,
respectively).
These
suggest
that
count,
INR,
PT
may
serve
as
potential
indicators
patients.
results
revealed
reduction
individuals
when
survivors.
However,
no
distinctions
observed
aPTT
survivor
groups.
On
other
hand,
there
noticeable
variations
estimated
PT,
D-Dimer
levels,
higher
values
group
those
who
survived.
Journal of Anesthesia Analgesia and Critical Care,
Journal Year:
2024,
Volume and Issue:
4(1)
Published: July 6, 2024
Abstract
Background
Lung
perfusion
defects,
mainly
due
to
endothelial
and
coagulation
activation,
are
a
key
contributor
COVID-19
respiratory
failure.
patients
may
also
develop
acute
kidney
injury
(AKI)
because
of
renal
deficit.
We
aimed
explore
AKI-associated
factors
the
independent
prediction
standardized
minute
ventilation
(MV)—a
proxy
alveolar
dead
space—on
AKI
onset
persistence
in
mechanically
ventilated
patients.
Methods
This
is
multicenter
observational
cohort
study.
enrolled
157
requiring
mechanical
intensive
care
unit
(ICU)
admission.
collected
clinical
information,
ventilation,
laboratory
data.
was
defined
by
2012
KDIGO
guidelines
classified
as
transient
or
persistent
according
serum
creatinine
criteria
within
48
h.
Ordered
univariate
multivariate
logistic
regression
analyses
were
employed
identify
variables
associated
with
persistence.
Results
Among
on
47%
developed
AKI:
10%
had
AKI,
37%
AKI.
The
degree
hypoxia
not
differences
severity.
Across
increasing
severity
groups,
despite
similar
levels
paCO
2
,
we
observed
an
increased
MV
MV,
robust
space.
After
adjusting
for
other
covariates,
remained
predictor
development
d
-dimer
higher
Conclusions
In
critically
ill
failure,
wasted
independently
greater
risk
These
hypothesis-generating
findings
suggest
that
derangements
link
pathophysiology
both
our
population.
Cardiovascular Therapeutics,
Journal Year:
2024,
Volume and Issue:
2024(1)
Published: Jan. 1, 2024
The
COVID-19
virus
not
only
has
significant
pathogenicity
but
also
influences
the
progression
of
many
diseases,
altering
patient
prognosis.
Cardiovascular
particularly
aortic
aneurysms,
are
among
most
life-threatening
conditions.